DaVita Venture Group
InvestorActiveDaVita Venture Group (DVG) is the corporate venture capital arm of DaVita Inc., a Fortune 500 kidney care provider, launched in May 2020 and headquartered in Denver, Colorado. DVG provides strategic capital and operational support to companies improving care for patients with kidney disease and related conditions. Its four investment priorities are Care Models (tech-enabled services, home treatments, value-based care), Digital Health (data and AI for care delivery), New Service Lines (adjacent verticals of clinical care), and Life Sciences (pharma, devices, and diagnostics). The group typically invests at Series A and beyond with check sizes of $1M–$10M, and all capital comes directly from DaVita. DVG also executes larger-scale corporate development transactions including acquisitions and joint ventures, and co-develops and pilots new care models through strategic partnerships. Beyond capital, DVG supports portfolio companies through board observerships or director roles, clinical and value-based care expertise, business development, hiring, and technical support.
Founder Intel
Sign in to read intel from founders who have worked with DaVita Venture Group.
What founders say about DaVita Venture Group
Be the first to share intel on DaVita Venture Group — it's free.
Get Started FreeRelated on The List
- AlbionVC — Investor · London, UK
- Bayern Kapital — Investor · Landshut, Bavaria, Germany
- Builders VC — Investor · San Francisco, CA, United States
- Cambridge Angels — Investor · Cambridge, United Kingdom
- Canaan Partners — Investor · Menlo Park, CA
Comparing options? Founders discuss fundraising in the forum, or browse the rest of The List.